| Description |
The model for new pharmaceutical product development is changing rapidly and your company’s strategy must respond, whether you are a large pharmaceutical company, or an emerging biotech company. Alternative sourcing programs are emerging. Alliances are becoming more and more central to new product development as alliance centric external development programs emerge. Movements towards better integration of business development and alliance management functions and integration of alliances and acquisition, are also transforming how companies are finding, evaluating, structuring and negotiating deals and working with their external partners to develop new products and commercialize those products.
www.healthtech.com
|
|
